Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety Study of Acellular Tissue Engineered Vessel for Coronary Artery Bypass

NCT: NCT07078370 · ENROLLING_BY_INVITATION

NCT IDNCT07078370
StatusENROLLING_BY_INVITATION
Start Date2025-08-28
Completion2027-07-31
SponsorVascudyne, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

To assess safety and feasibility of a coronary bypass created with Vascudyne Acellular Tissue Engineered Vessel (ATEV) with External Support Structure (ESS) in patients requiring multi vessel coronary artery bypass grafting (CABG).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑